Requires insurance and Medicaid coverage for inpatient and outpatient substance abuse treatment for a period of not less than forty-five days

2025 Regular Session Introduced by Billy Jones

Requires private insurance plans and Medicaid to cover substance use disorder treatment (inpatient and outpatient) for no less than 45 days.

ENACTING CLAUSE STRICKEN

Summary of Bill A 3366

A 3366 would require insurance plans and Medicaid to provide coverage for substance use disorder treatment in both inpatient and outpatient settings, with a stated minimum duration of treatment of not less than 45 days. The bill has not become law; the enacting clause has been struck.

Purpose and Intent

Establish a guaranteed coverage standard for substance abuse treatment services, ensuring both private insurance and Medicaid cover the cost of inpatient and outpatient care for a minimum period of 45 days.

Aim to improve access to comprehensive, longer-duration treatment for individuals with substance use disorders.

Key Provisions (as described)

Coverage Mandate: Requires insurance plans and Medicaid to cover substance abuse treatment services.

Settings Covered: Inpatient and outpatient treatment programs are included.

Minimum Duration: Treatment must be covered for no less than 45 days.

Scope: Applies to both private insurance coverage and Medicaid beneficiaries (public coverage).

Who Would Be Affected

Individuals with substance use disorders seeking treatment who rely on private insurance or Medicaid.

Insurers offering private plans (and their plan design requirements) and the state Medicaid program (including reimbursements to treatment providers).

Health care providers and treatment facilities offering inpatient or outpatient substance use disorder services.

Employers and plan sponsors that contract for self-insured or insured plans, insofar as required by state regulation.

Procedural and Timeline Aspects

Introduction: January 27, 2025.

Primary Sponsor: Billy Jones.

Legislative Path: Referred to the Assembly Insurance Committee on introduction (January 27, 2025).

Status (as of September 8, 2025): ENACTING CLAUSE STRICKEN (the enacting clause was removed, indicating the bill did not proceed to enactment in its current form). The duplicative entry reflects the same status update on the same date.

Related/Companion Legislation:

Related bills in prior sessions include A 7585, A 3041, A 902, A 2412.
A companion bill exists in the Senate: S 1430 (listed as companion).

Potential Impact if Enacted (contextual)

Access and Coverage: Potential expansion of treatment access through guaranteed minimum coverage duration in both private plans and Medicaid.

Financial/Administrative: Insurers and the Medicaid program would need to adjust benefit design, credibly cover at least 45 days of treatment, and modify provider reimbursement where applicable.

Systemic Effect: Could promote longer treatment episodes, potentially improving outcomes for individuals with substance use disorders.

Notes

As currently statused, the bill did not become law due to the enacting clause being struck. If reintroduced or amended, the same substantive provisions could be reconsidered.